GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Capex-to-Operating-Cash-Flow

Biogena Group Invest AG (WBO:BIO) Capex-to-Operating-Cash-Flow : 0.00 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Biogena Group Invest AG's Capital Expenditure for the six months ended in Jan. 2024 was €0.00 Mil. Its Cash Flow from Operations for the six months ended in Jan. 2024 was €0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Biogena Group Invest AG Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Biogena Group Invest AG's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Capex-to-Operating-Cash-Flow Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Capex-to-Operating-Cash-Flow
- - - -

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Capex-to-Operating-Cash-Flow - - - -

Competitive Comparison of Biogena Group Invest AG's Capex-to-Operating-Cash-Flow

For the Packaged Foods subindustry, Biogena Group Invest AG's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Capex-to-Operating-Cash-Flow Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Capex-to-Operating-Cash-Flow falls into.



Biogena Group Invest AG Capex-to-Operating-Cash-Flow Calculation

Biogena Group Invest AG's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Jan. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 0
=N/A

Biogena Group Invest AG's Capex-to-Operating-Cash-Flow for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Biogena Group Invest AG Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.